Secondary Logo

Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®


Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial

Thompson, Christopher C MD, MSc, FASGE, FACG1; Abu Dayyeh, Barham K MD, MPH2; Kushner, Robert MD, MS3; Sullivan, Shelby MD4; Schorr, Alan B DO, FAAIM, FACE5; Amaro, Anastassia MD6; Apovian, Caroline M MD7; Fullum, Terrence MD, FACS8; Zarrinpar, Amir MD9; Jensen, Michael D MD10; Stein, Adam C MD11; Edmundowicz, Steven MD12,26; Kahaleh, Michel MD, AGAF, FACG, FASGE13; Ryou, Marvin MD1; Bohning, Matthew J MD14; Ginsberg, Gregory MD15; Huang, Christopher MD16; Tran, Daniel D MD, FACS17; Glaser, Joseph P MD18; Martin, John A MD19,27; Jaffe, David L MD15; Farraye, Francis A MD, MSc16; Ho, Samuel B MD20; Kumar, Nitin MD1; Harakal, Donna BSN, RN, BC, CCRC19; Young, Meredith MS, RD, LD12; Thomas, Catherine E MS22; Shukla, Alpana P MD22; Ryan, Michele B MS23; Haas, Miki RN, BSN24; Goldsmith, Heidi RN, MS25; McCrea, Jennifer25; Aronne, Louis J MD22

Author Information
American Journal of Gastroenterology: March 2017 - Volume 112 - Issue 3 - p 447-457
doi: 10.1038/ajg.2016.500
  • Buy
  • SDC


© The American College of Gastroenterology 2017. All Rights Reserved.